Education
About Us
Working with TipRanks
Follow Us
Protara Therapeutics, Inc. (TARA)
:TARA
TARA Analyst Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TARA Stock 12 Month Forecast
Average Price Target
$25.00
▲(384.50% Upside)
| Highest Price Target$30.00 | Average Price Target$25.00 | Lowest Price Target$21.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
LifeSci Capital
$22→$26
Buy
403.88%
Upside
Reiterated
10/18/25
JonesTrading
$21
Buy
306.98%
Upside
Reiterated
10/16/25
H.C. Wainwright
$23
Buy
345.74%
Upside
Reiterated
10/09/25
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (NASDAQ: TARA), Kura Oncology (NASDAQ: KURA) and M3 (Other OTC: MTHRF)Valuation and risks to reaching our price target. Our price target of $23 is based on an equally weighted composite of: (a) $19.32/share, as a 35x multiple of taxed and diluted $1.53 discounted back to and (b) an NPV of $26.0/share (discounted cash flow analysis using a 12.0% discount rate and 2.0% growth rate, in line with the expected discount and growth parameters of an early development-stage biotechnology company). Risks to achieving our price target include regulatory, commercial, clinical development, manufacturing, financial, liability and intellectual property risks. H.C. WAINWRIGHT & CO.
Scotiabank
$12
Buy
132.56%
Upside
Reiterated
05/09/25
Cantor Fitzgerald
―
Buy
―
Initiated
03/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
LifeSci Capital
$22→$26
Buy
403.88%
Upside
Reiterated
10/18/25
JonesTrading
$21
Buy
306.98%
Upside
Reiterated
10/16/25
H.C. Wainwright
$23
Buy
345.74%
Upside
Reiterated
10/09/25
Analysts Offer Insights on Healthcare Companies: Protara Therapeutics (NASDAQ: TARA), Kura Oncology (NASDAQ: KURA) and M3 (Other OTC: MTHRF)Valuation and risks to reaching our price target. Our price target of $23 is based on an equally weighted composite of: (a) $19.32/share, as a 35x multiple of taxed and diluted $1.53 discounted back to and (b) an NPV of $26.0/share (discounted cash flow analysis using a 12.0% discount rate and 2.0% growth rate, in line with the expected discount and growth parameters of an early development-stage biotechnology company). Risks to achieving our price target include regulatory, commercial, clinical development, manufacturing, financial, liability and intellectual property risks. H.C. WAINWRIGHT & CO.
Scotiabank
$12
Buy
132.56%
Upside
Reiterated
05/09/25
Cantor Fitzgerald
―
Buy
―
Initiated
03/14/25
Best Analysts Covering Protara Therapeutics
1 Month
xxx
Success Rate
5/15 ratings generated profit
Average Return
+2.45%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +2.45% per trade.
3 Months
xxx
Success Rate
7/15 ratings generated profit
Average Return
+32.56%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 46.67% of your transactions generating a profit, with an average return of +32.56% per trade.
1 Year
2 Years
xxx
Success Rate
6/7 ratings generated profit
Average Return
+46.89%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +46.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TARA Analyst Recommendation Trends
Rating
May 25
Jun 25
Aug 25
Sep 25
Oct 25
Strong Buy
11
8
11
10
13
Buy
1
0
0
0
0
Hold
3
2
0
0
0
Sell
5
3
0
0
0
Strong Sell
0
0
0
0
0
total
20
13
11
10
13
Each month's total comprises the sum of three months' worth of ratings.
TARA Financial Forecast
TARA Stock Forecast FAQ
What is TARA’s average 12-month price target, according to analysts?
Based on analyst ratings, Protara Therapeutics, Inc.’s 12-month average price target is 25.00.
What is TARA’s upside potential, based on the analysts’ average price target?
Protara Therapeutics, Inc. has 384.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TARA a Buy, Sell or Hold?
Protara Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Protara Therapeutics, Inc.’s price target?
The average price target for Protara Therapeutics, Inc. is 25.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $30.00 ,the lowest forecast is $21.00. The average price target represents 384.50% Increase from the current price of $5.16.
The highest analyst price target is $30.00 ,the lowest forecast is $21.00. The average price target represents 384.50% Increase from the current price of $5.16.
What do analysts say about Protara Therapeutics, Inc.?
Protara Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of TARA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.